Breaking News Instant updates and real-time market news.

SQ

Square

$77.55

2.55 (3.40%)

, SHAK

Shake Shack

$48.65

1.17 (2.46%)

10:30
11/06/18
11/06
10:30
11/06/18
10:30

On The Fly: Top five analyst upgrades

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Square (SQ) upgraded to Buy from Neutral at Citi with analyst Peter Christiansen saying in addition to "robust" user acquisition spending, Square's planned ~35% headquarter expansion signals confidence in continued platform growth. 2. Shake Shack (SHAK) upgraded to Buy from Neutral at Longbow. 3. Enbridge (ENB) upgraded to Outperform from Market Perform at Wells Fargo with analyst Praneeth Satish saying Enbridge has eliminated funding concerns with asset sales and is now on a path to equity self-funding its entire five-year secured capex backlog. 4. Kosmos (KOS) upgraded to Buy from Neutral at Goldman Sachs with analyst Neil Mehta citing valuation. 5. Calix (CALX) upgraded to Outperform from Market Perform at Cowen with analyst Paul Silverstein citing the strong Q3 results and outlook along with a growing number of data points he sees that support the view that its new AXOS, EXOS and Cloud platforms will drive an inflection in profitable growth. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

SQ

Square

$77.55

2.55 (3.40%)

SHAK

Shake Shack

$48.65

1.17 (2.46%)

ENB

Enbridge

$32.91

0.58 (1.79%)

KOS

Kosmos

$6.24

-0.05 (-0.79%)

CALX

Calix

$8.97

1.45 (19.28%)

  • 06

    Nov

  • 07

    Nov

  • 09

    Nov

  • 13

    Nov

  • 13

    Nov

  • 15

    Nov

  • 26

    Nov

  • 12

    Dec

  • 18

    Dec

SQ Square
$77.55

2.55 (3.40%)

11/05/18
KEYB
11/05/18
NO CHANGE
Target $115
KEYB
Overweight
Square could generate 'significant' revenue upside, says KeyBanc
KeyBanc analyst Josh Beck believes Square could generate significant revenue upside based on Key First Look Data indicating sustained triple-digit Square Cash growth, strength in the NFIB survey data, KBCM seller survey, and Key First Look Data indicating little GPV deceleration. The analyst expects initial 2019 commentary to reflect top-line strength with elevated investment, a viewpoint he fully endorses. Beck recommends using the market pullback to establish a position in Square. He reiterates an Overweight rating and $115 price target on the shares.
11/06/18
SBSH
11/06/18
UPGRADE
Target $90
SBSH
Buy
Square upgraded to Buy from Neutral at Citi
Citi analyst Peter Christiansen upgraded Square to Buy from Neutral and raised his price target for the shares to $90 from $67. The stock closed yesterday down $2.75 to $75.01.In addition to "robust" user acquisition spending, Square's planned ~35% headquarter expansion signals confidence in continued platform growth, Christiansen tells investors in a research note. Further, he believes upcoming Q3 commentary on the overall health of the ecosystem, visibility into fiscal 2019, and progress on the CFO search "will be positive towards restoring momentum in the stock." The analyst adds that he has no reason to believe Square's CFO departure relates to a negative change in the company's forward prospects. After a deeper look into Square's investment spending/payback model, Christiansen lifted his 2019 adjusted revenue estimate by 8%, or 9 points above consensus expectations for 42% growth.
10/12/18
10/12/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. MICROSOFT UPGRADED TO OUTPERFORM AFTER PULLBACK: Macquarie analyst Sarah Hindlian upgraded Microsoft (MSFT) to Outperform from Neutral and raised her price target on the shares to $121, saying she is taking advantage of the pullback in shares. Hindlian views Microsoft as a relatively defensive name with long-term earnings power and expects a strong start to FY19 following constructive field work. CITI UPGRADES NETFLIX TO BUY: Citi analyst Mark May upgraded Netflix (NFLX) to Buy from Neutral with an unchanged price target of $375. The valuation, following this week's selloff, has reached a level that warrants an "opportunistic" upgrade to Buy, May said. Netflix has a highly recurring subscription-based revenue business that delivers "significant value" to consumers, and its management team has a strong track record of execution, the analyst contended. Further, he believes the company's fundamentals remain strong and that is has opportunity to continue growing international subscribers. SQUARE UPGRADED TO BUY AFTER PULLBACK: Canaccord Genuity analyst Michael Graham upgraded Square (SQ) to Buy from Hold and raised his price target for the shares to $90 from $60. The recent pullback in the shares creates a long-term opportunity in a "truly disruptive and well-run company," Graham said. He believes the departure of CFO Sarah Friar is more about going to a promising company as CEO rather than walking away from a risk. PIVOTAL UPGRADES SNAP TO BUY: Pivotal Research analyst Brian Wieser upgraded Snap (SNAP) to Buy from Hold while lowering his price target for the shares to $8 from $9. The analyst said that despite declining usage and liquidity, the data he looks at is showing a "widening user base, although one which is collectively reducing its time on the platform." It is not too late for management to find ways to reverse recent usage trends and generally improve monetization regardless of those usage trends, Wieser added. Further, the analyst believes Snap could become an attractive candidate to go private with the stock's price at current levels. JPMORGAN DOWNGRADES ESTEE LAUDER TO NEUTRAL: JPMorgan analyst Andrea Teixeira downgraded Estee Lauder (EL) to Neutral and lowered her price target for the shares to $138 from $154. There may be a deceleration in the travel retail channel ahead now that Chinese customs agents are implementing tighter controls at the border, according to local source, Teixeira noted. Further, she believes the de-rating in luxury peers related to the group's "outsized exposure" to Chinese consumers will likely put a cap on Estee Lauder's valuation as well. The analyst also sees less opportunity for earnings beats on margins in the near term given tariff costs.
10/17/18
RHCO
10/17/18
NO CHANGE
Target $74
RHCO
Hold
Square price target raised to $74 from $66 at SunTrust
SunTrust analyst Andrew Jeffrey raised his price target on Square to $74 but kept his Hold rating, noting that he is impressed by the company's innovation and "likely ongoing better than expected revenue growth" even though investors may be overestimating its total addressable market. Jeffrey further states that while the recent pullback "piques" his interest, but he does not see it as an opportunity to buy stock, adding that the recent abrupt departure by CFO Sarah Friar demands a "more forgiving" valuation.
SHAK Shake Shack
$48.65

1.17 (2.46%)

11/06/18
LBOW
11/06/18
UPGRADE
LBOW
Buy
Shake Shack upgraded to Buy from Neutral at Longbow
11/06/18
11/06/18
UPGRADE
Target $60

Buy
Shake Shack upgraded to Buy after selloff at Longbow
As previously reported, Longbow analyst Alton Stump upgraded Shake Shack to Buy from Neutral prior to the market open, stating that while the sharp negative reaction to Shake Shack's comp miss in Q3 was not surprising, he sees nothing wrong fundamentally with the business model that led to the "modest" sequential deceleration in comps last quarter. Stump, who is confident Shake Shack's same-store sales profile can return to at least low-single digit growth over the next year, set a $60 price target on the shares.
11/02/18
RHCO
11/02/18
NO CHANGE
Target $60
RHCO
Buy
Shake Shack price target lowered to $60 from $66 at SunTrust
SunTrust analyst Jake Bartlett lowered his price target on Shake Shack to $60 after its Q3 results saw a miss on comps, while the Q4 guidance implied continued pressure and "sales cannibalization from new stores". The analyst also keeps his Buy rating, noting that the company's unit growth story remains compelling, even though he expects "limited near term upside" in the stock until comps return to positive growth trends.
11/02/18
PIPR
11/02/18
NO CHANGE
Target $62
PIPR
Overweight
Shake Shack earnings selloff a buying opportunity, says Piper Jaffray
The Shake Shack same-store sales miss in Q3 "is modest" when considering the negative 0.7% result compared to the positive 0.9% consensus, but is likely viewed as more material considering negative versus positive performance, Piper Jaffray analyst Nicole Miller Regan tells investors in a post-earnings research note. However, the company continues to open very high volume restaurants and profits should be a measure of equal importance, says the analyst. Regan would use the post-earnings pullback as a long-term buying opportunity in Shake Shack. She lowered her price target for the shares to $62 from $64 and reiterates an Overweight rating on the name.
ENB Enbridge
$32.91

0.58 (1.79%)

10/04/18
UBSW
10/04/18
INITIATION
UBSW
Buy
Enbridge initiated with a Buy at UBS
UBS analyst Shneur Gershuni started Enbridge with a Buy rating and C$50 price target. The analyst believes the shares at current levels are not reflecting the company's progress on simplifications and leverage, as well the $22B of capital projects coming online through 2020.
11/05/18
WELS
11/05/18
UPGRADE
WELS
Outperform
Enbridge upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Praneeth Satish upgraded Enbridge to Outperform from Market Perform and raised his price target to CAD55 from CAD54.
11/06/18
WELS
11/06/18
UPGRADE
WELS
Outperform
Enbridge upgraded to Outperform from Market Perform at Wells Fargo
11/06/18
WELS
11/06/18
UPGRADE
WELS
Outperform
Wells sees 'compelling entry point' for Enbridge, upgrades to Outperform
Wells Fargo analyst Praneeth Satish last night upgraded Enbridge to Outperform from Market Perform and raised his price target for the shares to C$55 from C$54. Enbridge has eliminated funding concerns with asset sales and is now on a path to equity self-funding its entire five-year secured capex backlog, Satish tells investors in a research note. Further, rather than being a headwind, Mainline re-contracting is now a potential catalyst given an acute lack of pipeline takeaway capacity, says the analyst. In addition, Line 3 uncertainty is mostly eliminated following the Minnesota PUC's approval of the project, Satish adds. He believes the recent underperformance of the shares creates a "compelling entry point."
KOS Kosmos
$6.24

-0.05 (-0.79%)

11/01/18
11/01/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Tesla (TSLA) initiated with a Neutral at Roth Capital. 2. T-Mobile (TMUS) initiated with a Buy at Guggenheim. 3. Kosmos (KOS) initiated with a Buy at Berenberg. 4. Sellas Life Sciences (SLS) initiated with an Outperform at Oppenheimer. 5. OFS Credit (OCCI) initiated with a Buy at Ladenburg. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/01/18
BREN
11/01/18
INITIATION
Target $12
BREN
Buy
Kosmos initiated with a Buy at Berenberg
Berenberg analyst Ilkin Karimli initiated Kosmos with a Buy and $12 price target.
11/06/18
GSCO
11/06/18
UPGRADE
Target $9
GSCO
Buy
Kosmos upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Neil Mehta upgraded Kosmos Energy to Buy while lowering his price target for the shares to $9 from $11. The analyst tells investors to focus on the company's production upside and not its exploration risk. He cites valuation for the upgrade following the recent selloff in the shares.
10/02/18
GSCO
10/02/18
INITIATION
Target $11
GSCO
Neutral
Kosmos reinstated with a Neutral at Goldman Sachs
Goldman Sachs analyst Neil Mehta removed his Not Rated designation on shares of Kosmos Energy and put a Neutral rating on the name with an $11 price target. The analyst finds higher valuation upside elsewhere among his coverage.
CALX Calix
$8.97

1.45 (19.28%)

11/06/18
COWN
11/06/18
UPGRADE
Target $14
COWN
Outperform
Calix upgraded to Outperform at Cowen
As reported previously, Cowen analyst Paul Silverstein upgraded Calix to Outperform from Market Perform. The analyst cited the strong Q3 results and outlook along with a growing number of data points he sees that support the view that its new AXOS, EXOS and Cloud platforms will drive an inflection in profitable growth. Silverstein raised his price target to $14 from $6 on Calix shares.
11/06/18
COWN
11/06/18
UPGRADE
COWN
Outperform
Calix upgraded to Outperform from Market Perform at Cowen
02/14/18
02/14/18
UPGRADE
Target $9

Outperform
Calix upgraded to Outperform with $9 price target at Northland
As previously reported, Northland analyst Tim Savageaux upgraded Calix (CALX) to Outperform from Market Perform, stating that while its Q4 results missed expectations the company looks to have meaningfully addressed its operating expense and gross margin issues. While he expects slower growth as a ramp at Verizon (VZ) offsets weakness at CenturyLink (CTL), he estimates the company will turn from a loss to "solid profits" in FY18, Savageaux tells investors. He set a $9 price target on Calix shares.
02/14/18
COWN
02/14/18
NO CHANGE
Target $6
COWN
Market Perform
Calix story way ahead of numbers, says Cowen
Cowen analyst Paul Silverstein believes Calix's Q4 report marks the end to its change to a software-centric communications cloud and platform company. He believes the significant operating expenditures reduction will offset disappointing revenues and gross margins to drive earnings to his forecasts. Silverstein maintained his Market Perform rating and $6 price target on Calix shares.

TODAY'S FREE FLY STORIES

AMZN

Amazon.com

$1,608.88

-13.47 (-0.83%)

, XPO

XPO Logistics

$52.01

-7.535 (-12.65%)

13:26
02/16/19
02/16
13:26
02/16/19
13:26
Periodicals
Amazon a risk for almost every stock/sector, Barron's says »

Amazon (AMZN) is eating…

AMZN

Amazon.com

$1,608.88

-13.47 (-0.83%)

XPO

XPO Logistics

$52.01

-7.535 (-12.65%)

KR

Kroger

$29.50

0.54 (1.86%)

FAST

Fastenal

$62.97

0.61 (0.98%)

GWW

Grainger

$316.63

4.9 (1.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 03

    Mar

  • 18

    Mar

YETI

Yeti

$22.85

0.97 (4.43%)

13:20
02/16/19
02/16
13:20
02/16/19
13:20
Periodicals
Yeti stock has 60% upside, Barron's says »

Yeti Holdings stock…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

L

Loews

$46.67

0.785 (1.71%)

13:14
02/16/19
02/16
13:14
02/16/19
13:14
Periodicals
Investors can love Loews, Barron's says »

Loews is a $15B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

  • 28

    May

EQIX

Equinix

$421.53

1.16 (0.28%)

, COR

CoreSite Realty

$102.69

0.625 (0.61%)

13:10
02/16/19
02/16
13:10
02/16/19
13:10
Periodicals
Equinix, CoreSite Realty among stocks to play data-center boom, Barron's says »

Data-center stocks may…

EQIX

Equinix

$421.53

1.16 (0.28%)

COR

CoreSite Realty

$102.69

0.625 (0.61%)

IRM

Iron Mountain

$35.13

-0.14 (-0.40%)

INXN

Interxion

$64.65

0.81 (1.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 26

    Mar

  • 26

    Mar

NOK

Nokia

$6.31

0.015 (0.24%)

, ERIC

Ericsson

$9.36

0.015 (0.16%)

13:07
02/16/19
02/16
13:07
02/16/19
13:07
Periodicals
A U.S. ban of Huawei may benefit Ericsson, Samsung, Barron's says »

The next salvo in the…

NOK

Nokia

$6.31

0.015 (0.24%)

ERIC

Ericsson

$9.36

0.015 (0.16%)

SSNLF

Samsung

$0.00

(0.00%)

CSCO

Cisco

$49.45

1.05 (2.17%)

JNPR

Juniper

$27.12

0.16 (0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

COP

ConocoPhillips

$70.13

1.04 (1.51%)

, MUR

Murphy Oil

$29.23

0.59 (2.06%)

13:00
02/16/19
02/16
13:00
02/16/19
13:00
Periodicals
Dividend investors should look to oil stocks for big yields, Barron's says »

Energy stocks aren't…

COP

ConocoPhillips

$70.13

1.04 (1.51%)

MUR

Murphy Oil

$29.23

0.59 (2.06%)

CVX

Chevron

$119.30

1.19 (1.01%)

VLO

Valero

$84.34

0.75 (0.90%)

XOM

Exxon Mobil

$77.74

1.47 (1.93%)

MRO

Marathon Oil

$17.07

0.15 (0.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Mar

  • 07

    Mar

  • 18

    Mar

  • 22

    May

  • 28

    May

AMZN

Amazon.com

$1,608.88

-13.47 (-0.83%)

12:45
02/16/19
02/16
12:45
02/16/19
12:45
Periodicals
Protestors against NY's Amazon HQ2 got math wrong, Barron's says »

On Thursday, Amazon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

  • 20

    Feb

  • 20

    Feb

  • 03

    Mar

  • 18

    Mar

ICE

IntercontinentalExchange

$75.49

-0.46 (-0.61%)

, NDAQ

Nasdaq

$87.74

0.56 (0.64%)

12:28
02/16/19
02/16
12:28
02/16/19
12:28
Periodicals
Investors interested in U.S. cannabis companies face challenges, Barron's says »

Investors interested in…

ICE

IntercontinentalExchange

$75.49

-0.46 (-0.61%)

NDAQ

Nasdaq

$87.74

0.56 (0.64%)

CGC

Canopy Growth

$47.54

1.49 (3.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

  • 28

    May

  • 15

    Feb

AMD

AMD

$23.68

0.55 (2.38%)

, INTC

Intel

$51.64

0.85 (1.67%)

08:43
02/16/19
02/16
08:43
02/16/19
08:43
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AMD

AMD

$23.68

0.55 (2.38%)

INTC

Intel

$51.64

0.85 (1.67%)

MRVL

Marvell

$18.82

-0.37 (-1.93%)

MCHP

Microchip

$91.10

0.49 (0.54%)

MU

Micron

$41.99

-0.23 (-0.54%)

NVDA

Nvidia

$157.22

2.69 (1.74%)

QCOM

Qualcomm

$51.97

0.42 (0.81%)

TXN

Texas Instruments

$107.55

0.57 (0.53%)

TWTR

Twitter

$31.23

0.28 (0.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

  • 25

    Feb

  • 07

    Mar

  • 07

    Mar

  • 25

    Mar

  • 26

    Mar

  • 28

    May

  • 04

    Jun

  • 05

    Jun

AMGN

Amgen

$188.31

1.6 (0.86%)

, ALPMY

Astellas Pharma

$0.00

(0.00%)

04:55
02/16/19
02/16
04:55
02/16/19
04:55
Conference/Events
American Society of Clinical Oncology to hold a symposium »

2019 ASCO Genitourinary…

AMGN

Amgen

$188.31

1.6 (0.86%)

ALPMY

Astellas Pharma

$0.00

(0.00%)

AZN

AstraZeneca

$40.92

0.93 (2.33%)

BAYRY

Bayer

$0.00

(0.00%)

BMY

Bristol-Myers

$51.64

0.81 (1.59%)

CALA

Calithera Biosciences

$5.35

0.14 (2.69%)

CLVS

Clovis

$25.44

(0.00%)

DNA

Bought by RHHBY

$0.00

(0.00%)

ESALY

Eisai

$0.00

(0.00%)

EXEL

Exelixis

$22.26

-0.05 (-0.22%)

IMMU

Immunomedics

$14.23

0.225 (1.61%)

INO

Inovio

$3.70

0.01 (0.27%)

MRK

Merck

$79.84

0.9 (1.14%)

MYOV

Myovant Sciences

$21.48

0.1 (0.47%)

MYGN

Myriad Genetics

$31.41

0.53 (1.72%)

NH

NantHealth

$0.60

(0.00%)

NVS

Novartis

$89.89

0.865 (0.97%)

PFE

Pfizer

$42.41

0.45 (1.07%)

PGNX

Progenics

$4.87

0.13 (2.74%)

SGEN

Seattle Genetics

$71.48

2.92 (4.26%)

SNY

Sanofi

$42.51

0.94 (2.26%)

TYME

Tyme Technologies

$3.19

0.055 (1.76%)

AVEO

Aveo Pharmaceuticals

$0.62

0.0092 (1.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

  • 16

    Feb

  • 19

    Feb

  • 20

    Feb

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 28

    Feb

  • 07

    Mar

  • 11

    Mar

  • 22

    Mar

  • 11

    Apr

  • 28

    Apr

  • 18

    May

  • 20

    May

WES

Western Gas Partners

$49.52

0.38 (0.77%)

, WGP

Western Gas Equity

$32.38

0.2 (0.62%)

19:30
02/15/19
02/15
19:30
02/15/19
19:30
Recommendations
Western Gas Partners, Western Gas Equity analyst commentary at MUFG »

MUFG raises price targets…

WES

Western Gas Partners

$49.52

0.38 (0.77%)

WGP

Western Gas Equity

$32.38

0.2 (0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Feb

  • 15

    Feb

  • 04

    Mar

PXD

Pioneer Natural

$145.33

2.27 (1.59%)

19:19
02/15/19
02/15
19:19
02/15/19
19:19
Recommendations
Pioneer Natural analyst commentary at MUFG »

Pioneer Natural price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

ZTS

Zoetis

$95.38

2.16 (2.32%)

18:42
02/15/19
02/15
18:42
02/15/19
18:42
Hot Stocks
Zoetis CEO says: 'Diagnostics are more important in animals than humans' »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$136.40

2.13 (1.59%)

18:22
02/15/19
02/15
18:22
02/15/19
18:22
Hot Stocks
Johnson & Johnson CEO: 'We ended 2018 with great results' »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

  • 25

    Feb

  • 25

    Feb

  • 06

    Mar

WIN

Windstream

$3.37

0.2 (6.31%)

, UNIT

Uniti Group

$20.00

0.53 (2.72%)

18:18
02/15/19
02/15
18:18
02/15/19
18:18
Periodicals
Court says Windstream defaulted on bonds in 2015, Bloomberg says »

A court has ruled that…

WIN

Windstream

$3.37

0.2 (6.31%)

UNIT

Uniti Group

$20.00

0.53 (2.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 28

    Feb

BHVN

Biohaven Pharmaceutical

$45.32

1.36 (3.09%)

18:14
02/15/19
02/15
18:14
02/15/19
18:14
Hot Stocks
Biohaven treatment of multiple system atrophy granted FDA orphan designation »

According to a post on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$188.31

1.6 (0.86%)

18:11
02/15/19
02/15
18:11
02/15/19
18:11
Hot Stocks
Amgen treatment of Acute Myeloid Leukemia granted FDA orphan designation »

According to a post on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$100.19

1.19 (1.20%)

18:02
02/15/19
02/15
18:02
02/15/19
18:02
Hot Stocks
Celanese announces Acetyl Intermediates price increases in China »

Celanese will increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIN

Windstream

$3.37

0.2 (6.31%)

, UNIT

Uniti Group

$20.00

0.53 (2.72%)

17:58
02/15/19
02/15
17:58
02/15/19
17:58
Periodicals
Court says Windstream defaulted on bonds in 2015, Bloomberg says »

A court has ruled that…

WIN

Windstream

$3.37

0.2 (6.31%)

UNIT

Uniti Group

$20.00

0.53 (2.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 28

    Feb

GLD

SPDR Gold Shares

$124.81

0.77 (0.62%)

17:41
02/15/19
02/15
17:41
02/15/19
17:41
Hot Stocks
SPDR Gold Shares holdings fall to 793.03MT from 796.85MT »

This is the lowest level…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDLZ

Mondelez

$48.17

0.84 (1.77%)

17:26
02/15/19
02/15
17:26
02/15/19
17:26
Hot Stocks
Mondelez to transfer listing of debt securities to Nasdaq »

Mondelez International,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

  • 06

    Mar

  • 28

    May

FN

Fabrinet

$55.23

0.67 (1.23%)

17:25
02/15/19
02/15
17:25
02/15/19
17:25
Hot Stocks
Fabrinet CFO sells 20K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

  • 04

    Mar

UBER

Uber

$0.00

(0.00%)

17:24
02/15/19
02/15
17:24
02/15/19
17:24
Periodicals
Uber sues NYC over move to cap number of ride-hailing drivers, Bloomberg says »

Uber is suing New York…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$277.40

2.93 (1.07%)

17:19
02/15/19
02/15
17:19
02/15/19
17:19
Periodicals
House Democrats to probe POTUS emergency declaration, Bloomberg says »

The House Judiciary…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$277.40

2.93 (1.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$51.71

0.25 (0.49%)

17:11
02/15/19
02/15
17:11
02/15/19
17:11
Hot Stocks
Oracle authorizes additional $12B stock buyback under existing program »

In a regulatory 8K…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

  • 06

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.